Department of Cardiovascular Medicine, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei Province, China.
College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei Province, China.
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241276524. doi: 10.1177/10760296241276524.
Non-ST-segment elevation acute myocardial infarction (NSTEMI) is a life-threatening clinical emergency with a poor prognosis. However, there are no individualized nomogram models to identify patients at high risk of NSTEMI who may undergo death. The aim of this study was to develop a nomogram for in-hospital mortality in patients with NSTEMI to facilitate rapid risk stratification of patients. A total of 774 non-diabetic patients with NSTEMI were included in this study. Least Absolute Shrinkage and Selection Operator regression was used to initially screen potential predictors. Univariate and multivariate logistic regression (backward stepwise selection) analyses were performed to identify the optimal predictors for the prediction model. The corresponding nomogram was constructed based on those predictors. The receiver operating characteristic curve, GiViTI calibration plot, and decision curve analysis (DCA) were used to evaluate the performance of the nomogram. The nomogram model consisting of six predictors: age (OR = 1.10; 95% CI: 1.05-1.15), blood urea nitrogen (OR = 1.06; 95% CI: 1.00-1.12), albumin (OR = 0.93; 95% CI: 0.87-1.00), triglyceride (OR = 1.41; 95% CI: 1.09-2.00), D-dimer (OR = 1.39; 95% CI: 1.06-1.80), and aspirin (OR = 0.16; 95% CI: 0.06-0.42). The nomogram had good discrimination (area under the curve (AUC) = 0.89, 95% CI: 0.84-0.94), calibration, and clinical usefulness. In this study, we developed a nomogram model to predict in-hospital mortality in patients with NSTEMI based on common clinical indicators. The proposed nomogram has good performance, allowing rapid risk stratification of patients with NSTEMI.
非 ST 段抬高型急性心肌梗死(NSTEMI)是一种危及生命的临床急症,预后不良。然而,目前尚无针对 NSTEMI 患者死亡风险的个体化列线图模型。本研究旨在建立 NSTEMI 患者院内死亡的列线图模型,以方便快速对患者进行风险分层。本研究共纳入 774 例非糖尿病 NSTEMI 患者。采用最小绝对收缩和选择算子回归初步筛选潜在预测因子。采用单因素和多因素逻辑回归(逐步向后选择)分析确定预测模型的最佳预测因子。根据这些预测因子构建相应的列线图。采用受试者工作特征曲线、GiViTI 校准图和决策曲线分析(DCA)评估列线图的性能。该列线图模型由 6 个预测因子组成:年龄(OR=1.10;95%CI:1.05-1.15)、血尿素氮(OR=1.06;95%CI:1.00-1.12)、白蛋白(OR=0.93;95%CI:0.87-1.00)、甘油三酯(OR=1.41;95%CI:1.09-2.00)、D-二聚体(OR=1.39;95%CI:1.06-1.80)和阿司匹林(OR=0.16;95%CI:0.06-0.42)。该列线图具有良好的区分度(曲线下面积(AUC)=0.89,95%CI:0.84-0.94)、校准度和临床实用性。本研究基于常见的临床指标建立了预测 NSTEMI 患者院内死亡的列线图模型。所提出的列线图具有良好的性能,可快速对 NSTEMI 患者进行风险分层。